Viewing StudyNCT06497556

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06497556
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2024-07-05
Brief Title: A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer
KRAS G12C Lung Cancer
Keywords:
Name View
Advanced Non-Small Cell Lung Cancer View
KRAS G12 Lung Cancer View
Advanced Lung Cancer View
Metastatic lung cancer View
Divarasib View
KRAS G12C Inhibitor View
KRAS G12C Positive View
KRAS Mutation View
KRAS G12C Mutation View
Lung Cancer Mutation View